Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • Challenges In Bringing Personalized Cancer Vaccines To The Clinic

    Bio-IT World Contributed Commentary | The cancer vaccine industry faces a challenge: How to transition from prediction to effective vaccine therapy?

    Jun 21, 2018
  • Alexion’s Quest To Test The Algorithm Of Rare Disease Diagnosis

    Bio-IT World | Alexion, in collaboration with EPAM, has developed a software competition platform to allow the objective comparison of contributed algorithms for automated rare disease diagnosis.

    Jun 20, 2018
  • Roche Pays $2.4 Billion For Rest Of Cancer Expert Foundation Medicine

    Reuters | Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine, raising its bet on the U.S. genomic profiling group's ability to personalize cancer care.

    Jun 19, 2018
  • Celgene’s LabAlert System Focuses On Scientific Workflow Efficiency, User Experience

    Bio-IT World | Innovative mobile technology that quickly sends warnings and error notifications to users’ mobile devices won a Bio-IT World 2018 Best Practices Award. The Celgene Lab Instrument Mobile Alert (LabAlert) system integrates into the laboratory environment to generate, manage, and report real-time alerts from lab instruments to mobile devices.

    Jun 18, 2018
  • «
  • 301
  • 302
  • 303
  • 304
  • 305
  • 306
  • 307
  • 308
  • 309 (current)
  • 310
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy